Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individualsEugènia Negredo, Bonaventura Clotet, Peré Domingo et al.|Journal of Antimicrobial Chemotherapy|2016Cited by 11